Tendler C L, Burton J D, Jaffe J, Danielpour D, Charley M, McCoy J P, Pittelkow M R, Waldmann T A
Division of Pediatric Oncology, Mount Sinai School of Medicine, New York, New York 10029-6574.
Cancer Res. 1994 Aug 15;54(16):4430-5.
The Sézary syndrome (SzS) and adult T-cell leukemia (ATL) are malignant proliferations of mature T-lymphocytes that possess distinct functions. Sézary cells function as helper cells, whereas ATL cells are usually suppressor effectors. Although phenotypically similar (CD4+/CD7-/CD8-), these functional differences between the T-cell lymphoproliferative disorders suggest different patterns of cytokine expression. We wished to delineate the cytokine mechanisms potentially underlying the diverse functional characteristics of SzS and ATL. Therefore, we analyzed the expression of interleukins (IL) 2, 4, and 5, gamma-interferon, and transforming growth factor beta 1 in the highly purified leukemic T-cells from 5 SzS and 5 ATL patients. Decreased mRNA and protein levels of IL-2, gamma-interferon, and IL-5 were detected in mitogen-stimulated ATL and SzS cells when compared to similarly cultured normal CD4+ cells. In contrast, IL-4 production was markedly up-regulated in the leukemic cells of 4/5 SzS patients as compared to ATL and normal controls. Finally, fresh ATL cells secreted higher levels of transforming growth factor beta 1 into the culture medium than the malignant T-cells from SzS patients. Collectively these results suggest that, similar to the murine CD4-expressing T-cell subsets Th1 and Th2, different cytokine profiles exist in a human population of CD4+ T-cells. Moreover, the distinct patterns of IL-4 and transforming growth factor beta 1 expression by SzS and ATL cells, respectively, are most consistent with the functional differences (i.e., helper versus suppressor activity) between these T-cell malignancies and thus may play important roles in the pathogenesis of the paraneoplastic features associated with these two leukemias.
Sezary综合征(SzS)和成人T细胞白血病(ATL)是具有不同功能的成熟T淋巴细胞的恶性增殖。Sezary细胞起辅助细胞的作用,而ATL细胞通常是抑制效应细胞。尽管在表型上相似(CD4+/CD7-/CD8-),但这些T细胞淋巴增殖性疾病之间的功能差异表明细胞因子表达模式不同。我们希望描绘出可能是SzS和ATL不同功能特征基础的细胞因子机制。因此,我们分析了来自5例SzS患者和5例ATL患者的高度纯化的白血病T细胞中白细胞介素(IL)2、4和5、γ干扰素以及转化生长因子β1的表达。与同样培养的正常CD4+细胞相比,在有丝分裂原刺激的ATL和SzS细胞中检测到IL-2、γ干扰素和IL-5的mRNA和蛋白质水平降低。相反,与ATL和正常对照相比,4/5例SzS患者的白血病细胞中IL-4的产生明显上调。最后,新鲜的ATL细胞比SzS患者的恶性T细胞向培养基中分泌更高水平的转化生长因子β1。这些结果共同表明,与表达小鼠CD4的T细胞亚群Th1和Th2类似,在人类CD4+T细胞群体中存在不同的细胞因子谱。此外,SzS和ATL细胞分别表达IL-4和转化生长因子β1的不同模式与这些T细胞恶性肿瘤之间的功能差异(即辅助与抑制活性)最为一致,因此可能在与这两种白血病相关的副肿瘤特征的发病机制中起重要作用。